RAS and ROS in rhabdomyosarcoma.
Publication
, Journal Article
Zhang, M; Linardic, CM; Kirsch, DG
Published in: Cancer Cell
December 9, 2013
The 5-year survival for localized rhabdomyosarcoma is over 70%, but only 30% for patients presenting with metastatic disease. In this issue of Cancer Cell, Chen and colleagues performed whole-genome and RNA sequencing on human rhabdomyosarcoma and identified RAS mutations and oxidative stress as potential therapeutic targets for high-risk embryonal rhabdomyosarcoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Cell
DOI
EISSN
1878-3686
Publication Date
December 9, 2013
Volume
24
Issue
6
Start / End Page
689 / 691
Location
United States
Related Subject Headings
- Rhabdomyosarcoma, Embryonal
- Oxidative Stress
- Oncology & Carcinogenesis
- Humans
- Animals
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, M., Linardic, C. M., & Kirsch, D. G. (2013). RAS and ROS in rhabdomyosarcoma. Cancer Cell, 24(6), 689–691. https://doi.org/10.1016/j.ccr.2013.11.015
Zhang, Minsi, Corinne M. Linardic, and David G. Kirsch. “RAS and ROS in rhabdomyosarcoma.” Cancer Cell 24, no. 6 (December 9, 2013): 689–91. https://doi.org/10.1016/j.ccr.2013.11.015.
Zhang M, Linardic CM, Kirsch DG. RAS and ROS in rhabdomyosarcoma. Cancer Cell. 2013 Dec 9;24(6):689–91.
Zhang, Minsi, et al. “RAS and ROS in rhabdomyosarcoma.” Cancer Cell, vol. 24, no. 6, Dec. 2013, pp. 689–91. Pubmed, doi:10.1016/j.ccr.2013.11.015.
Zhang M, Linardic CM, Kirsch DG. RAS and ROS in rhabdomyosarcoma. Cancer Cell. 2013 Dec 9;24(6):689–691.
Published In
Cancer Cell
DOI
EISSN
1878-3686
Publication Date
December 9, 2013
Volume
24
Issue
6
Start / End Page
689 / 691
Location
United States
Related Subject Headings
- Rhabdomyosarcoma, Embryonal
- Oxidative Stress
- Oncology & Carcinogenesis
- Humans
- Animals
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences